Corline Biomedical Ab Stock Fundamentals
| CLBIO Stock | SEK 6.42 0.18 2.73% |
Corline Biomedical AB fundamentals help investors to digest information that contributes to Corline Biomedical's financial success or failures. It also enables traders to predict the movement of Corline Stock. The fundamental analysis module provides a way to measure Corline Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Corline Biomedical stock.
Corline |
Corline Biomedical AB Company Operating Margin Analysis
Corline Biomedical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Corline Biomedical Operating Margin | 0.02 % |
Most of Corline Biomedical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Corline Biomedical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Corline Biomedical AB has an Operating Margin of 0.0228%. This is 100.06% lower than that of the Healthcare sector and 100.02% lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is 100.41% lower than that of the firm.
Corline Biomedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Corline Biomedical's current stock value. Our valuation model uses many indicators to compare Corline Biomedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Corline Biomedical competition to find correlations between indicators driving Corline Biomedical's intrinsic value. More Info.Corline Biomedical AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.59 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Corline Biomedical AB is roughly 1.70 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Corline Biomedical's earnings, one of the primary drivers of an investment's value.Corline Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Corline Biomedical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Corline Biomedical could also be used in its relative valuation, which is a method of valuing Corline Biomedical by comparing valuation metrics of similar companies.Corline Biomedical is currently under evaluation in operating margin category among its peers.
Corline Fundamentals
| Return On Equity | 0.0075 | |||
| Return On Asset | 0.0044 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 178.43 M | |||
| Shares Outstanding | 21.49 M | |||
| Shares Owned By Insiders | 54.88 % | |||
| Shares Owned By Institutions | 14.21 % | |||
| Price To Earning | (19.42) X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 7.06 M | |||
| Gross Profit | 9.1 M | |||
| EBITDA | (6.88 M) | |||
| Net Income | (6.92 M) | |||
| Cash And Equivalents | 41.63 M | |||
| Cash Per Share | 1.45 X | |||
| Current Ratio | 3.99 X | |||
| Book Value Per Share | 4.38 X | |||
| Cash Flow From Operations | (4.83 M) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 29.0 | |||
| Number Of Employees | 10 | |||
| Beta | 0.8 | |||
| Market Capitalization | 203.87 M | |||
| Total Asset | 101.66 M | |||
| Net Asset | 101.66 M |
About Corline Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corline Biomedical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corline Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corline Biomedical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. The company was founded in 1991 and is based in Uppsala, Sweden. Corline Biomedical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 9 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.